Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MEDVidi vs PlushCare

MEDVidi
Graded #384

Lower grade

vs+16.5
PlushCare
Graded #64

Higher grade

The verdict

PlushCare takes it — 74.5/100 to 58/100.

PlushCare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlushCare +29
45
74
Dose & formulationPlushCare +24
53
77
Clinical oversightPlushCare +5
77
82
Labs & monitoringPlushCare +15
62
77
FulfillmentPlushCare +19
59
78
Contract termsMEDVidi +14
55
41
MEDVidi · left barPlushCare · right bar

The numbers

MetricMEDVidiPlushCare
WeighScore58/10074.5/100
GradeCC
Scorecard rank#384#64
SemaglutideNot disclosed$149/mo (starting dose, compounded)
TirzepatideNot disclosed$399/mo (starting dose, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
MEDVidi

Graded #384 · C

Strengths

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

Where it loses points

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated
PlushCare

Graded #64 · C

Strengths

  • Available in all 50 states
  • Appointments with US board-certified physicians, not nurse practitioners only
  • Virtual primary care — the same doctor can manage GLP-1s alongside other health needs
  • Owned by Transcarent, a venture-backed health platform with a named corporate parent

Where it loses points

  • Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
  • GLP-1 prescribing is up to the clinician at the visit — not guaranteed at signup
  • BBB complaints center on the membership cancellation process

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard